UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Frailty and sarcopenia: definitions and outcome parameters

Osteoporosis international, 2012-07, Vol.23 (7), p.1839-1848

2012

Volltextzugriff (PDF)

Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper

Calcified tissue international, 2012-05, Vol.90 (5), p.343-353

2012

Volltextzugriff (PDF)

Tools in the Assessment of Sarcopenia

Calcified tissue international, 2013-09, Vol.93 (3), p.201-210

2013

Volltextzugriff (PDF)

Management of osteoporosis of the oldest old

Osteoporosis international, 2014-11, Vol.25 (11), p.2507-2529

2014

Volltextzugriff (PDF)

Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys ( Macaca fascicularis)

Bone (New York, N.Y.), 2001-08, Vol.29 (2), p.176-179

2001

Volltextzugriff (PDF)

Adherence to treatment of osteoporosis : a need for study

Osteoporosis international, 2007-10, Vol.18 (10), p.1311-1317

2007

Volltextzugriff (PDF)

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Annals of the Rheumatic Diseases, 2011-10, Vol.70 (10), p.1713-1718

2011

Volltextzugriff (PDF)

S12911-2 reduces bone loss induced by short-term immobilization in rats

Bone (New York, N.Y.), 2003-07, Vol.33 (1), p.115-123

2003

Volltextzugriff (PDF)

Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

Osteoporosis international, 2012-01, Vol.23 (1), p.193-199

2012

Volltextzugriff (PDF)

Strontium Ranelate Increases Cartilage Matrix Formation

Journal of bone and mineral research, 2001-02, Vol.16 (2), p.299-308

2001

Volltextzugriff (PDF)

The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro

Bone (New York, N.Y.), 1996-06, Vol.18 (6), p.517-523

1996

Volltextzugriff (PDF)

Erratum to: Management of osteoporosis of the oldest old

Osteoporosis international, 2014-11, Vol.25 (11), p.2531-2531

2014

Volltextzugriff (PDF)

Health claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in Science

Current medical research and opinion, 2012-04, Vol.28 (4), p.611-616

2012

Volltextzugriff (PDF)

In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation

European journal of pharmacology, 2002-08, Vol.450 (1), p.11-17

2002

Volltextzugriff (PDF)

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Osteoporosis international, 2008-09, Vol.19 (9), p.1247-1250

2008

Volltextzugriff (PDF)

S 12911‐2 Inhibits Osteoclastic Bone Resorption In Vitro

Journal of bone and mineral research, 2003-06, Vol.18 (6), p.1082-1087

2003

Volltextzugriff (PDF)

Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis

Osteoporosis international, 2002-11, Vol.13 (11), p.841-857

2002

Volltextzugriff (PDF)

Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect

Bone (New York, N.Y.), 1996-03, Vol.18 (3), p.253-259

1996

Volltextzugriff (PDF)

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Osteoporosis international, 2009-03, Vol.20 (3), p.497-498

2009

Volltextzugriff (PDF)

Rational for a minimum data set for clinical trials with geriatric patients

The Journal of nutrition, health & aging, 2007-05, Vol.11 (3), p.273-277

2007

Volltextzugriff (PDF)

Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg

International angiology, 1989-10, Vol.8 (4 Suppl), p.53

Tsouderos, Y

1989

Volltextzugriff (PDF)

Scientific research and therapeutic innovation: an ambition-sharing

M.S. Médecine sciences, 2004-10, Vol.20 (10), p.935-937

2004

Volltextzugriff (PDF)

Re: “Effect of long-term treatment with strontium ranelate on bone strontium content” by Bärenholdt et al. (Bone, 2009)

Bone (New York, N.Y.), 2009-11, Vol.45 (5), p.1024-1025

2009

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Human Health Sciences
(37)
Sciences De La Santé Humaine
(37)
Life Sciences & Biomedicine
(36)
Science & Technology
(36)
General & Internal Medicine
(35)
Humans
(32)
Médecine Générale & Interne
(31)
Endocrinology & Metabolism
(21)
Female
(21)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Male
(13)
Pharmacology. Drug Treatments
(13)
Animals
(12)
Orthopedics
(12)
Rheumatology
(11)
Bone Density - Drug Effects
(9)
Organometallic Compounds - Pharmacology
(9)
Osteoporosis
(9)
Thiophenes - Pharmacology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Frailty and sarcopenia: definitions and outcome parameters

Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper

Tools in the Assessment of Sarcopenia

Management of osteoporosis of the oldest old

Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys ( Macaca fascicularis)

Adherence to treatment of osteoporosis : a need for study

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

S12911-2 reduces bone loss induced by short-term immobilization in rats

Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

Strontium Ranelate Increases Cartilage Matrix Formation

The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro

Erratum to: Management of osteoporosis of the oldest old

Health claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in Science

In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

S 12911‐2 Inhibits Osteoclastic Bone Resorption In Vitro

Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis

Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Rational for a minimum data set for clinical trials with geriatric patients

Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg

Scientific research and therapeutic innovation: an ambition-sharing

Re: “Effect of long-term treatment with strontium ranelate on bone strontium content” by Bärenholdt et al. (Bone, 2009)

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty

Suchergebnisse filtern